Chronic kidney disease consecutive to chemotherapy for chondroblastic osteosarcoma: A report on 6 pediatric cases (notice n° 759931)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02136cam a2200289 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250123102022.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Paul, Alice |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Chronic kidney disease consecutive to chemotherapy for chondroblastic osteosarcoma: A report on 6 pediatric cases |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2021.<br/> |
500 ## - GENERAL NOTE | |
General note | 87 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Background. – The management of osteosarcoma in children and adolescents is based on polychemotherapy including several nephrotoxic drugs (e.g. ifosfamide, methotrexate, and cisplatinum). Chronic renal toxicity is a frequent complication but stage 5 chronic kidney disease requiring dialysis is rare. We report here a series of six pediatric patients with osteosarcoma displaying chronic kidney disease after chemotherapy. Case-diagnosis/treatment. – We retrospectively reviewed the medical charts, mainly for clinical history, timing between chemotherapy and development of tubulopathy and CKD, type of therapies and global evolution (chronic dialysis and further renal transplantation, n = 2; death, n = 1). Notably, all patients suffered from chondroblastic osteosarcoma. Conclusions. – Advanced chronic kidney disease can be a complication of osteosarcoma management that could more frequently lead to dialysis and further transplantation. It would be interesting to identify specific risk factors of such renal toxicity. The chondroblastic sub-type may be associated with such susceptibility, but this needs to be confirmed. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Ifosfamide |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Nephrotoxicity |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Chondroblastic osteosarcoma |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Chronic kidney disease |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Pediatric tumor |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Glomerular toxicity |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Duncan, Anita |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bacchetta, Justine |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dubourg, Laurence |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marec-Bérard, Perrine |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tanné, Corentin |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Néphrologie & Thérapeutique | Volume 17 | 7 | 2021-07-26 | p. 543-546 | 1769-7255 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-nephrologie-et-therapeutique-2021-7-page-543?lang=en&redirect-ssocas=7080">https://shs.cairn.info/revue-nephrologie-et-therapeutique-2021-7-page-543?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux